Pixium Vision achieves implantation of 10 patients in its clinical trial with its innovative 150 electrodes IRIS® II bionic vision systemadmin2019-09-11T17:32:32+02:00January 11th, 2017|
Pixium Vision appoints Robert J.W. ten Hoedt as independent member to Board of Directorsadmin2019-09-11T17:32:32+02:00January 3rd, 2017|
Pixium Vision and Silamir, honoured at Quai d’Orsay, during the Award Ceremony of Janus 2016 from French Institute of Designadmin2019-09-11T17:32:32+02:00November 22nd, 2016|
Pixium Vision announces the first successful implantation and activation of IRIS® II, 150 electrode bionic vision system, in the UKadmin2019-09-11T17:32:53+02:00November 7th, 2016|
Pixium Vision: Results for the First 9 Months of 2016admin2019-09-11T17:33:41+02:00October 27th, 2016|
Pixium Vision announces an 11 million Euros bond financing facilityadmin2019-09-11T17:32:53+02:00September 29th, 2016|
Pixium Vision receives clinical trial approval from Spanish Ministry of Health for 150 electrode IRIS®II bionic vision systemadmin2019-09-11T17:32:53+02:00September 12th, 2016|
Pixium Vision announces CE market approval of IRIS®II, its first bionic vision systemadmin2019-09-11T17:32:54+02:00July 25th, 2016|
PIXIUM VISION ANNOUNCES H1 2016 RESULTS AND PROVIDES A BUSINESS UPDATEadmin2019-09-11T17:32:55+02:00July 20th, 2016|
Pixium Vision receives clinical trial approval from UK Regulatory Authority for 150 electrode IRIS®II bionic vision systemadmin2019-09-11T17:32:58+02:00May 31st, 2016|
Pixium Vision and research partners report significant progress on PRIMA, a tiny wireless sub-retinal implant during ARVOadmin2019-09-11T17:32:59+02:00May 4th, 2016|
Pixium Vision announces its first quarter 2016 financial updateadmin2019-09-11T17:32:59+02:00April 27th, 2016|
